Analysts expect Cipla to return up to 30% from here on as India biz gains momentum

Kotak Securities said the expansion of the Covid portfolio would support near-term earnings while the continued rollout of respiratory franchisee in the US and strong execution of One India strategy will drive the company’s earnings growth over FY23-24.

https://ift.tt/2RZRyFQ